The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models.
- DOI
- 10.1038/s41419-025-08397-z
- Published
- 2026 Jan 8
- Container
- Cell death & disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-025-08397-z,
title = {The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models.},
author = {Bianchi G and Pastorino F and Rolandi G and Ciampi E and Segalerba D and De Giovanni B and Cafferata B and Balbi M and Ravera S and Vellone VG and Ponzoni M and Brignole C},
year = {2026},
journal = {Cell death \& disease},
doi = {10.1038/s41419-025-08397-z},
url = {https://doi.org/10.1038/s41419-025-08397-z}
}RIS
TY - JOUR TI - The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models. AU - Bianchi G AU - Pastorino F AU - Rolandi G AU - Ciampi E AU - Segalerba D AU - De Giovanni B AU - Cafferata B AU - Balbi M AU - Ravera S AU - Vellone VG AU - Ponzoni M AU - Brignole C PY - 2026 JO - Cell death & disease DO - 10.1038/s41419-025-08397-z UR - https://doi.org/10.1038/s41419-025-08397-z ER -
APA
G, B., F, P., G, R., E, C., D, S., B, D. G., B, C., M, B., S, R., VG, V., M, P., & C, B. (2026). The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models.. Cell death & disease. https://doi.org/10.1038/s41419-025-08397-z
Source records
- pubmed · retrieved 2026-09-27T13:22:23.862Z
- europe-pmc · retrieved 2026-09-27T13:22:23.871Z
- doaj · retrieved 2026-09-27T13:22:23.854Z